ATLAS BIOGRAFERNE ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.2% 1.2% 3.9% 10.2% 4.6%  
Credit score (0-100)  82 81 49 23 40  
Credit rating  A A BBB BB BBB  
Credit limit (kDKK)  103.4 87.7 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  6,786 6,439 6,531 6,376 6,352  
EBITDA  2,437 1,856 1,177 994 1,668  
EBIT  977 431 -269 -843 -90.7  
Pre-tax profit (PTP)  450.0 205.0 -431.0 -1,017.0 -363.0  
Net earnings  348.0 156.0 -452.0 -783.0 -286.4  
Pre-tax profit without non-rec. items  450 205 -431 -1,017 -363  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  7,837 7,026 6,619 6,553 7,695  
Shareholders equity total  2,102 2,258 1,806 1,023 736  
Interest-bearing liabilities  5,419 2,666 1,953 3,257 8,608  
Balance sheet total (assets)  11,784 10,364 9,363 10,919 15,766  

Net Debt  2,988 1,270 1,161 1,724 2,967  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  6,786 6,439 6,531 6,376 6,352  
Gross profit growth  21.0% -5.1% 1.4% -2.4% -0.4%  
Employees  13 13 12 12 9  
Employee growth %  8.3% 0.0% -7.7% 0.0% -25.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  11,784 10,364 9,363 10,919 15,766  
Balance sheet change%  -3.7% -12.1% -9.7% 16.6% 44.4%  
Added value  2,437.0 1,856.0 1,177.0 603.0 1,668.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -2,273 -2,236 -1,853 -1,903 -616  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 -1.0 -2.0 -3.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  14.4% 6.7% -4.1% -13.2% -1.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  8.1% 3.9% -2.7% -8.3% -0.6%  
ROI %  11.7% 5.8% -4.2% -16.5% -1.2%  
ROE %  18.0% 7.2% -22.2% -55.4% -32.6%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  17.8% 21.8% 19.3% 9.4% 4.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  122.6% 68.4% 98.6% 173.4% 177.9%  
Gearing %  257.8% 118.1% 108.1% 318.4% 1,168.9%  
Net interest  0 0 0 0 0  
Financing costs %  8.4% 5.6% 7.0% 6.7% 4.7%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.6 0.5 0.3 0.4 1.0  
Current Ratio  0.6 0.5 0.4 0.6 1.2  
Cash and cash equivalent  2,431.0 1,396.0 792.0 1,533.0 5,641.3  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -1,704.0 -2,084.0 -2,977.0 -2,048.0 1,146.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  187 143 98 50 185  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  187 143 98 83 185  
EBIT / employee  75 33 -22 -70 -10  
Net earnings / employee  27 12 -38 -65 -32